Selected research
Industry Growth & Trends
Global Tissue and Organ Transplantation Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Tissue and Organ Transplantation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Tissue and Organ Transplantation market include Arthrex, Biolife Solutions, Discovery Life Sciences, Medtronic, Stryker Corporation, Teva Pharmaceuticals, Veloxis Pharmaceutical, Zimmer Biomet and Abbvie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tissue and Organ Transplantation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tissue and Organ Transplantation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tissue and Organ Transplantation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tissue and Organ Transplantation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tissue and Organ Transplantation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tissue and Organ Transplantation Market by Company
Arthrex
Biolife Solutions
Discovery Life Sciences
Medtronic
Stryker Corporation
Teva Pharmaceuticals
Veloxis Pharmaceutical
Zimmer Biomet
Abbvie
Novartis
Tissue and Organ Transplantation Segment by Type
Preservation Solution
Immunosuppressive Drugs
Tissue Products
Tissue and Organ Transplantation Segment by Application
Hospital
Transplant Centers
Others
Tissue and Organ Transplantation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue and Organ Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue and Organ Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue and Organ Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tissue and Organ Transplantation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Preservation Solution
- Immunosuppressive Drugs
- Tissue Products
Applications
- Hospital
- Transplant Centers
- Others
Companies covered
- Arthrex
- Biolife Solutions
- Discovery Life Sciences
- Medtronic
- Stryker Corporation
- Teva Pharmaceuticals
- Veloxis Pharmaceutical
- Zimmer Biomet
- Abbvie
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tissue and Organ Transplantation Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tissue and Organ Transplantation Market Size by Region (2021-2032)
- 1.4.1 Global Tissue and Organ Transplantation Market Size by Region (2021-2026)
- 1.4.2 Global Tissue and Organ Transplantation Market Size by Region (2027-2032)
- 1.5 Key Regions Tissue and Organ Transplantation Market Size (2021-2032)
- 1.5.1 North America Tissue and Organ Transplantation Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tissue and Organ Transplantation Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tissue and Organ Transplantation Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tissue and Organ Transplantation Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tissue and Organ Transplantation Market Size Growth Rate (2021-2032)
2 Tissue and Organ Transplantation Market by Type
- 2.1 Type Introduction
- 2.1.1 Preservation Solution
- 2.1.2 Immunosuppressive Drugs
- 2.1.3 Tissue Products
- 2.2 Global Tissue and Organ Transplantation Market Size by Type
- 2.2.1 Global Tissue and Organ Transplantation Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tissue and Organ Transplantation Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tissue and Organ Transplantation Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tissue and Organ Transplantation Market Size by Regions
- 2.3.1 North America Tissue and Organ Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tissue and Organ Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tissue and Organ Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tissue and Organ Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tissue and Organ Transplantation Market Size Breakdown by Type (2021-2026)
3 Tissue and Organ Transplantation Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Transplant Centers
- 3.1.3 Others
- 3.2 Global Tissue and Organ Transplantation Market Size by Application
- 3.2.1 Global Tissue and Organ Transplantation Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tissue and Organ Transplantation Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tissue and Organ Transplantation Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tissue and Organ Transplantation Market Size by Regions
- 3.3.1 North America Tissue and Organ Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tissue and Organ Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tissue and Organ Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tissue and Organ Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tissue and Organ Transplantation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tissue and Organ Transplantation Industry Trends
- 4.2 Tissue and Organ Transplantation Industry Drivers
- 4.3 Tissue and Organ Transplantation Industry Opportunities and Challenges
- 4.4 Tissue and Organ Transplantation Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tissue and Organ Transplantation Revenue (2021-2026)
- 5.2 Global Tissue and Organ Transplantation Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tissue and Organ Transplantation Key Company Headquarters & Area Served
- 5.4 Global Tissue and Organ Transplantation Company, Product Type & Application
- 5.5 Global Tissue and Organ Transplantation Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tissue and Organ Transplantation Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tissue and Organ Transplantation Players Market Share by Revenue in 2025
- 5.6.3 2025 Tissue and Organ Transplantation Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Arthrex
- 6.1.1 Arthrex Company Information
- 6.1.2 Arthrex Business Overview
- 6.1.3 Arthrex Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Arthrex Tissue and Organ Transplantation Product Portfolio
- 6.1.5 Arthrex Recent Developments
- 6.2 Biolife Solutions
- 6.2.1 Biolife Solutions Company Information
- 6.2.2 Biolife Solutions Business Overview
- 6.2.3 Biolife Solutions Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Biolife Solutions Tissue and Organ Transplantation Product Portfolio
- 6.2.5 Biolife Solutions Recent Developments
- 6.3 Discovery Life Sciences
- 6.3.1 Discovery Life Sciences Company Information
- 6.3.2 Discovery Life Sciences Business Overview
- 6.3.3 Discovery Life Sciences Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio
- 6.3.5 Discovery Life Sciences Recent Developments
- 6.4 Medtronic
- 6.4.1 Medtronic Company Information
- 6.4.2 Medtronic Business Overview
- 6.4.3 Medtronic Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Medtronic Tissue and Organ Transplantation Product Portfolio
- 6.4.5 Medtronic Recent Developments
- 6.5 Stryker Corporation
- 6.5.1 Stryker Corporation Company Information
- 6.5.2 Stryker Corporation Business Overview
- 6.5.3 Stryker Corporation Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Stryker Corporation Tissue and Organ Transplantation Product Portfolio
- 6.5.5 Stryker Corporation Recent Developments
- 6.6 Teva Pharmaceuticals
- 6.6.1 Teva Pharmaceuticals Company Information
- 6.6.2 Teva Pharmaceuticals Business Overview
- 6.6.3 Teva Pharmaceuticals Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio
- 6.6.5 Teva Pharmaceuticals Recent Developments
- 6.7 Veloxis Pharmaceutical
- 6.7.1 Veloxis Pharmaceutical Company Information
- 6.7.2 Veloxis Pharmaceutical Business Overview
- 6.7.3 Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio
- 6.7.5 Veloxis Pharmaceutical Recent Developments
- 6.8 Zimmer Biomet
- 6.8.1 Zimmer Biomet Company Information
- 6.8.2 Zimmer Biomet Business Overview
- 6.8.3 Zimmer Biomet Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Zimmer Biomet Tissue and Organ Transplantation Product Portfolio
- 6.8.5 Zimmer Biomet Recent Developments
- 6.9 Abbvie
- 6.9.1 Abbvie Company Information
- 6.9.2 Abbvie Business Overview
- 6.9.3 Abbvie Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Abbvie Tissue and Organ Transplantation Product Portfolio
- 6.9.5 Abbvie Recent Developments
- 6.10 Novartis
- 6.10.1 Novartis Company Information
- 6.10.2 Novartis Business Overview
- 6.10.3 Novartis Tissue and Organ Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Novartis Tissue and Organ Transplantation Product Portfolio
- 6.10.5 Novartis Recent Developments
7 North America
- 7.1 North America Tissue and Organ Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 7.3 North America Tissue and Organ Transplantation Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tissue and Organ Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 8.3 Europe Tissue and Organ Transplantation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tissue and Organ Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tissue and Organ Transplantation Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tissue and Organ Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 10.3 South America Tissue and Organ Transplantation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tissue and Organ Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tissue and Organ Transplantation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst